These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38873935)

  • 21. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
    Wang X; Masri S; Phung S; Chen S
    Cancer Res; 2008 Apr; 68(7):2259-65. PubMed ID: 18381432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
    Bormann F; Stinzing S; Tierling S; Morkel M; Markelova MR; Walter J; Weichert W; Roßner F; Kuhn N; Perner J; Dietz J; Ispasanie S; Dietel M; Schäfer R; Heinemann V; Sers C
    Int J Cancer; 2019 Feb; 144(3):569-581. PubMed ID: 30252132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase.
    Fang L; Yu Y; Li Y; Wang S; Zhang R; Guo Y; Li Y; Yan Y; Sun YP
    Hum Reprod; 2019 Oct; 34(10):2018-2026. PubMed ID: 31553790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity
    Liu Y; Liu X; Zhang N; Yin M; Dong J; Zeng Q; Mao G; Song D; Liu L; Deng H
    Acta Pharm Sin B; 2020 Dec; 10(12):2299-2312. PubMed ID: 33354502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome.
    Hong M; Kim JW; Kim MK; Chung BW; Ahn SK
    J Cancer; 2020; 11(24):7246-7252. PubMed ID: 33193888
    [No Abstract]   [Full Text] [Related]  

  • 26. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
    Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Ichikawa Y; Kobayashi A; Shibahara T; Yanagawa Y; Higuchi H; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2021 Dec; 9(4):1573-1583. PubMed ID: 34414683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-neoplastic effects of amphiregulin in colorectal carcinogenesis.
    Guzman MJ; Shao J; Sheng H
    J Gastrointest Cancer; 2013 Jun; 44(2):211-21. PubMed ID: 23263765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells.
    Yang M; Liu P; Wang K; Glorieux C; Hu Y; Wen S; Jiang W; Huang P
    Mol Oncol; 2017 Apr; 11(4):358-372. PubMed ID: 28218497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
    Busser B; Sancey L; Josserand V; Niang C; Favrot MC; Coll JL; Hurbin A
    Mol Ther; 2010 Mar; 18(3):528-35. PubMed ID: 19826406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
    Hack SP; Zhu AX; Wang Y
    Front Immunol; 2020; 11():598877. PubMed ID: 33250900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Significance of Programmed Death Ligand-1 Expression in Esophageal Squamous Cell Carcinoma.
    Ito N; Tsujimoto H; Horiguchi H; Shimazaki H; Miyazaki H; Saitoh D; Kishi Y; Ueno H
    J Surg Res; 2020 Jul; 251():321-328. PubMed ID: 32200323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis.
    Ding L; Liu T; Wu Z; Hu B; Nakashima T; Ullenbruch M; Gonzalez De Los Santos F; Phan SH
    J Immunol; 2016 Jul; 197(1):303-12. PubMed ID: 27206766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.
    Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW
    Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
    Sternlicht MD; Sunnarborg SW
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer.
    Lofgren KA; Sreekumar S; Jenkins EC; Ernzen KJ; Kenny PA
    Antib Ther; 2021 Oct; 4(4):252-261. PubMed ID: 34877472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiregulin inhibits TNF-α-induced alveolar epithelial cell death through EGFR signaling pathway.
    Meng C; Wang S; Wang X; Lv J; Zeng W; Chang R; Li Q; Wang X
    Biomed Pharmacother; 2020 May; 125():109995. PubMed ID: 32187954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of Amphiregulin Triggers Doxorubicin-Induced Autophagic and Apoptotic Death by Regulating Endoplasmic Reticulum Stress in Glioblastoma Cells.
    Lee IN; Yang JT; Hsieh MJ; Huang C; Huang HC; Ku YJ; Wu YP; Huang KC; Chen JC
    J Mol Neurosci; 2020 Oct; 70(10):1461-1470. PubMed ID: 32472393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
    Davies LC; Heldring N; Kadri N; Le Blanc K
    Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.